← back to search

Constantinos Zamboglou

University of Freiburg · DE
Area of research
Pulmonary and Respiratory Medicine · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Prostate Cancer Treatment and Research, Prostate Cancer Diagnosis and Treatment, Advanced Radiotherapy Techniques, and Radiomics and Machine Learning in Medical Imaging.
h-index
31
citations
3,230
works
227
NIH funding
primary concept
email

Recent publications

In silico oncology: a mechanistic multiscale model of clinical prostate cancer response to external radiation therapy as the core of a digital (virtual) twin. Sensitivity analysis and a clinical adaptation approach
Frontiers in Physiology 2025cited by 9position: middledoi
Can PSMA PET detect intratumour heterogeneity in histological PSMA expression of primary prostate cancer? Analysis of [68Ga]Ga-PSMA-11 and [18F]PSMA-1007
European Journal of Nuclear Medicine and Molecular Imaging 2025cited by 8position: middledoi
Safety and quality of life of PSMA-PET- and MRI-based focal dose escalated radiotherapy for intermediate- and high-risk prostate cancer: Primary endpoint analysis of the bi-centric phase II HypoFocal trial (ARO2020-01)
Radiotherapy and Oncology 2025cited by 7position: middledoi
Biomarkers in prostate cancer: current status and future directions in radiotherapy—statement from the Prostate Cancer Working Group of the German Society of Radiation Oncology (DEGRO)
Strahlentherapie und Onkologie 2025cited by 1position: middledoi
Exploring the role of combined external beam radiotherapy and targeted radioligand therapy with [<sup>177</sup>Lu]Lu-PSMA-617 for prostate cancer - from bench to bedside
Theranostics 2024cited by 18position: middledoi
Radiomics-based prediction of local control in patients with brain metastases following postoperative stereotactic radiotherapy
Neuro-Oncology 2024cited by 16position: middledoi
A convolutional attention model for predicting response to chemo-immunotherapy from ultrasound elastography in mouse tumor models
Communications Medicine 2024cited by 10position: middledoi
European association of urology risk stratification predicts outcome in patients receiving PSMA-PET-planned salvage radiotherapy for biochemical recurrence following radical prostatectomy
Radiotherapy and Oncology 2024cited by 8position: middledoi
Comparison of data fusion strategies for automated prostate lesion detection using mpMRI correlated with whole mount histology
Radiation Oncology 2024cited by 5position: middledoi
Implementation of PET/CT in radiation oncology—a patterns-of-care analysis of the German Society of Nuclear Medicine and the German Society of Radiation Oncology
Strahlentherapie und Onkologie 2024cited by 5position: middledoi
Predicting cisplatin tolerability in older adults with head and neck cancer – Insights for improved chemoradiation outcomes
Radiotherapy and Oncology 2024cited by 5position: middledoi
Outcome of intraoperative brachytherapy as a salvage treatment for locally recurrent rectal cancer
Strahlentherapie und Onkologie 2024cited by 1position: middledoi
A student trained convolutional neural network competing with a commercial AI software and experts in organ at risk segmentation
Scientific Reports 2024cited by 1position: middledoi
Investigation and benchmarking of U-Nets on prostate segmentation tasks
Computerized Medical Imaging and Graphics 2023cited by 32position: middledoi
Development and Validation of a Multi-institutional Nomogram of Outcomes for PSMA-PET–Based Salvage Radiotherapy for Recurrent Prostate Cancer
JAMA Network Open 2023cited by 30position: firstdoi
Evaluation of Concomitant Systemic Treatment in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Radiotherapy
JAMA Network Open 2023cited by 29position: middledoi
ESTRO-ACROP recommendations for evidence-based use of androgen deprivation therapy in combination with external-beam radiotherapy in prostate cancer
Radiotherapy and Oncology 2023cited by 27position: middledoi
The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomy
European Journal of Nuclear Medicine and Molecular Imaging 2023cited by 23position: middledoi
Towards Improving the Efficacy of PSMA-Targeting Radionuclide Therapy for Late-Stage Prostate Cancer—Combination Strategies
Current Oncology Reports 2023cited by 23position: middledoi
Deep learning based automated delineation of the intraprostatic gross tumour volume in PSMA-PET for patients with primary prostate cancer
Radiotherapy and Oncology 2023cited by 22position: lastdoi
PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA &lt; 0.2 ng/ml
European Journal of Nuclear Medicine and Molecular Imaging 2023cited by 20position: lastdoi
Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapy
European Journal of Nuclear Medicine and Molecular Imaging 2023cited by 20position: middledoi
Salvage radiotherapy is effective in patients with PSMA-PET-negative biochemical recurrence- results of a retrospective study
Radiotherapy and Oncology 2023cited by 20position: middledoi
Identifying core MRI sequences for reliable automatic brain metastasis segmentation
Radiotherapy and Oncology 2023cited by 15position: middledoi
A Multicenter Evaluation of Different Chemotherapy Regimens in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Chemoradiation
International Journal of Radiation Oncology*Biology*Physics 2023cited by 11position: middledoi
Toxicity and Patient Reported Quality of Life after PSMA-PET and mpMRT-Based Focal Dose Escalated Definitive Radiotherapy in Prostate Cancer Patients: 2-Year Follow-Up of the HypoFocal Phase II Trial
International Journal of Radiation Oncology*Biology*Physics 2023cited by 1position: middledoi
Identifying core MRI sequences for reliable automatic brain metastasis segmentation
medRxiv 2023cited by 1position: middledoi
Explainable AI for CNN-based prostate tumor segmentation in multi-parametric MRI correlated to whole mount histopathology
Radiation Oncology 2022cited by 48position: middledoi
PSMA-PET- and MRI-Based Focal Dose Escalated Radiation Therapy of Primary Prostate Cancer: Planned Safety Analysis of a Nonrandomized 2-Armed Phase 2 Trial (ARO2020-01)
International Journal of Radiation Oncology*Biology*Physics 2022cited by 43position: firstdoi
Metastasis-Free Survival and Patterns of Distant Metastatic Disease After Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA-PET)-Guided Salvage Radiation Therapy in Recurrent or Persistent Prostate Cancer After Prostatectomy
International Journal of Radiation Oncology*Biology*Physics 2022cited by 31position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Anca‐Ligia Grosu · German Marine Research Consortium67 papers (2015–2025)Nils Hendrik Nicolay · University Hospital Leipzig36 papers (2019–2024)Simon K. B. Spohn · University of Freiburg30 papers (2019–2025)Dimos Baltas · University of Freiburg28 papers (2016–2025)Tanja Sprave · University of Freiburg24 papers (2020–2025)Michael Mix · University Medical Center Freiburg20 papers (2016–2025)Cordula A. Jilg · University Medical Center Freiburg18 papers (2015–2025)Matthias Benndorf · University of Freiburg17 papers (2019–2024)Juri Ruf · Public Citizen17 papers (2019–2023)Tobias Fechter · University of Freiburg17 papers (2015–2025)Eleni Gkika · Deutschen Konsortium für Translationale Krebsforschung15 papers (2018–2022)Simon Kirste · University of Freiburg14 papers (2015–2025)Philipp T. Meyer · University Medical Center Freiburg14 papers (2015–2024)Christian Gratzke · University Medical Center Freiburg13 papers (2019–2025)Raluca Stoian · University of Freiburg13 papers (2020–2024)Erik Haehl · LMU Klinikum12 papers (2020–2022)Peter Bronsert · University of Freiburg12 papers (2018–2025)Michael Bock · University of Freiburg11 papers (2015–2024)Nina-Sophie Schmidt-Hegemann · LMU Klinikum11 papers (2018–2025)Ilias Sachpazidis · University of Freiburg11 papers (2017–2025)